SLC1A2 and Anxiety: Conversely, reducing astrocyte GLT-1 activity with pharmacological or genetic tools (AAV-delivered shRNA) restored stress-mediated anxiety levels to those observed in naive mice, while keeping the distance traveled in the OFT unaltered, and reversed the hyperactivity of glutamatergic neurons in the BLA triggered by chronic stress.